No Detail Found!

Role of Gemcitabine as a Radiosensitizer in Glioblastoma Multiforme Treatment.

Author(s)
Ayesha Quddus Aga Khan University Hospital, Karachi,Pakistan
Muhammad Shahzad Shamim Aga Khan University Hospital, Karachi,Pakistan
Abstract
Treatment for glioblastoma multiforme comprises of surgical resection of the tumour followed by radiotherapy and chemotherapy. Temozolomide is the routinely used radiosensitizer during radiotherapy and chemotherapy cycles and has shown good results. An alternative to temozolomide is gemcitabine, which is still under evaluation for use as a potential radiosensitizer. We review the current evidence for the efficacy and safety of gemcitabine as an alternative to temozolomide in GBM treatment including those cases of GBM that do not respond to standard post-operative temozolomide therapy.
Publication Details
Page(s) 324-326
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 2, Year: 2018

Request the full text from PASTIC

Keywords
Pakistan, Paediatric
References
Group GM. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. The Lancet. 2002; 359: 1011-8.
PauwelsB,KorstAE,LardonF,VermorkenJB,,2005,Combined modality therapy of gemcitabine and radiation,The Oncologist,10,34,51
PauwelsB,KorstAE,LambrechtsHA,PattynGG,de PooterCM,LardonF,,2006,The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro,Cancer Chemotherapy and Pharmacology,58,219,28
SigmondJ,HoneywellRJ,PostmaTJ,DirvenCM,De LangeSM,Van der BornK,,2009,Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer,Annals of Oncology,20,182,7
GertlerSZ,MacDonaldD,GoodyearM,ForsythP,StewartDJ,BelangerK,,2000,NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND. 94),Annals of Oncology,11,315,8
RiegerJ,DurkaS,StrefferJ,DichgansJ,WellerM.,,1999,Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone,Eur J Pharmacol,365,301,8
WellerM,StrefferJ,WickW,KortmannRD,HeissE,KükerW,,2001,Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma,Cancer,91,423,7
WickW,HermissonM,KortmannRD,KükerWM,DuffnerF,DichgansJ,,2002,Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma,J Neuro-Oncol,59,151,5
FabiA,MirriA,FeliciA,VidiriA,PaceA,OcchipintiE,,2008,Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study,J Neuro-Oncol,87,79,84
MetroG,FabiA,MirriMA,VidiriA,PaceA,CarosiM,,2010,Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme,Cancer Chemother Pharmacol,65,391,
KimMM,Camelo-PiraguaS,SchipperM,TaoY,NormolleD,JunckL,,2016,Gemcitabine Plus Radiation Therapy for HighGrade Glioma: Long-Term Results of a Phase 1 DoseEscalation Study,Int J Radiation Oncol Biol Physics,94,305,11
0

Citations

0

Downloads

36

Views